<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-11</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-11</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>53</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç©ºé—´è½¬å½•ç»„å­¦ï¼ˆSpatial Transcriptomicsï¼‰æŠ€æœ¯åœ¨è‚¿ç˜¤å¾®ç¯å¢ƒå’Œå‘è‚²è°ƒæ§ä¸­çš„åº”ç”¨å–å¾—æ–°è¿›å±•ï¼Œæ­ç¤ºäº†å¤šä¸­å¿ƒå°è‚ ç±»ç™Œè‚¿ç˜¤çš„å±€éƒ¨å¼‚è´¨æ€§ä»¥åŠå…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚ï¼ˆICIsï¼‰åœ¨å¿ƒè„ç±»å™¨å®˜ä¸­çš„å…ç–«éä¾èµ–æ€§åº”ç­”ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å¾®ç¯å¢ƒä¸æ²»ç–—å“åº”ï¼šåˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è§£æå°è‚ ç±»ç™Œè‚¿ç˜¤çš„å±€éƒ¨äºšå‹ç‰¹å¼‚æ€§åŠä¿¡å·é€šè·¯ï¼Œè¯„ä¼°ICIsè”åˆç–—æ³•çš„ååŒæ•ˆåº”ï¼Œå¹¶ç ”ç©¶TP53çªå˜æ€¥æ€§é«“ç³»ç™½è¡€ç—…çš„æ²»ç–—é¶ç‚¹ã€‚<br />
- å‘è‚²ç”Ÿç‰©å­¦ä¸è¡¨è§‚é—ä¼ ï¼šæ¢ç´¢SMARCA5â€“DMRT1å¤åˆç‰©åœ¨é›„æ€§ç”Ÿæ®–ç»†èƒå‘è‚²ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§ä½œç”¨ã€‚<br />
- ç–¾ç—…æ¨¡å‹ä¸æœºåˆ¶ç ”ç©¶ï¼šé€šè¿‡å•ç»†èƒè½¬å½•ç»„å­¦åˆ†æé˜¿å°”èŒ¨æµ·é»˜ç—…ã€è‚ºçº¤ç»´åŒ–ã€å¿ƒè‚Œæ¢—æ­»ç­‰ç–¾ç—…æ¨¡å‹ä¸­çš„ç»†èƒè½¬å½•æ¨¡å¼å’Œå…ç–«ç»†èƒåŠŸèƒ½ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç©ºé—´è½¬å½•ç»„å­¦ï¼ˆSpatial Transcriptomicsï¼‰å’Œå•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰æŠ€æœ¯è¢«å¹¿æ³›åº”ç”¨äºè§£æå¤æ‚ç”Ÿç‰©ä½“ç³»çš„ç»†èƒå¼‚è´¨æ€§å’Œå¾®ç¯å¢ƒã€‚<br />
- ç»“åˆå¤šç»„å­¦æ•°æ®ï¼ˆå¦‚ATAC-seqã€GLORI-Seqã€DRSï¼‰æ·±å…¥æ­ç¤ºåŸºå› è°ƒæ§ã€è¡¨è§‚é—ä¼ ä¿®é¥°å’Œç—…æ¯’-å®¿ä¸»ç›¸äº’ä½œç”¨ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡æ­ç¤ºåµå·¢ç™Œå¿«é€Ÿè…¹è…”è½¬ç§»çš„ç»†èƒæœºåˆ¶ï¼Œåµå·¢ç™Œç»†èƒä¸è…¹è…”å†…æ­£å¸¸ä¿æŠ¤ç»†èƒå½¢æˆâ€œç§˜å¯†è”ç›Ÿâ€ï¼ŒååŒä¾µè¢­ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- åµå·¢ç™Œç»†èƒä¸è…¹è…”æ­£å¸¸ç»†èƒçš„ååŒä¾µè¢­æœºåˆ¶<br />
- åµå·¢ç™Œç»†èƒå¦‚ä½•æ‹›å‹Ÿå¹¶åˆ©ç”¨å®¿ä¸»ç»†èƒè¿›è¡Œè½¬ç§»</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å‘ç°åµå·¢ç™Œç»†èƒä¸è…¹è…”å†…æ­£å¸¸ç»†èƒå½¢æˆæ··åˆç»†èƒç¾¤çš„æœºåˆ¶<br />
- æ­ç¤ºè¯¥è”ç›Ÿåœ¨ä¿ƒè¿›ç™Œç»†èƒä¾µè¢­å’Œè½¬ç§»ä¸­çš„ä½œç”¨</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (52æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE301265 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºå¤šç¶æ€§å°è‚ ç¥ç»å†…åˆ†æ³Œè‚¿ç˜¤çš„å±€éƒ¨äºšå‹ç‰¹å¼‚æ€§ç‰¹å¾å’Œä¿¡å·ä¼ å¯¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomicsã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Akitada Yogo ; Naoki Akanuma ; Grace E Kim ; Eric K NakakuraSeries Type : OtherOrganism : Homo sapiensSmall intestinal neuroendocrine tumors (SI-NETs) frequently present as multifocal lesions, but the spatial and molecular mechanisms underlying their development and heterogeneity remain unclear. This study aimed to characterize the phenotypic subtypes of tumor cells across anatomical sites in multifocal SI-NETs and identify local microenvironmental factors influencing tumor development.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301265" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>åˆ©ç”¨CosMXç©ºé—´è½¬å½•ç»„å­¦åˆ†æå°é¼ çš®ä¸‹EO771è‚¿ç˜¤ï¼Œç ”ç©¶NEDD8è€—ç«­å’ŒæŠ—PD-1ç–—æ³•çš„ååŒä½œç”¨ï¼ˆGSE318797ï¼‰ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Papakyriacou Irineos ; Lu Yonglin ; Bedos Marta Rubies ; Jarvius Malin ; Lapins Maris ; Puigvert Jordi Carreras ; Mao YuMaoSeries Type : OtherOrganism : Mus musculusWe have established the phenotype that depletion of NEDD8 in tumor cell has synergestic effect with anti-PD1 therapy in mouse EO771 subcutaneous tumor model. In this study we performed CosMX spatial transcriptomics of mouse tumor samples to study the tumor intrinsic and immune environment changes that could explain the outcome.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318797" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE264319 åˆ†æå¹²ç»†èƒæ¥æºçš„å¿ƒè„ç±»å™¨å®˜å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„å…ç–«éä¾èµ–æ€§ååº” [scRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€cardiacã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dilip Thomas ; Yu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe use of antibody based immune-checkpoint inhibitors (ICIs) have been highly successful in clinical treatment of several cancers. Despite the compelling efficacy of these drugs with their high binding affinity, there is incomplete understanding of non-target interactions in vivo. In this regard, ICIs are also known to cause immune-related adverse events (iRAEs) arising from infiltration of immune cells in tissues such as the heart. Due to the frequency of ICI treatments, extended half-life and the late onset of cardiac events, concerns have been raised regarding potential direct interactions of ICIs with major cellular cell types of the heart. The direct effects of these drugs in patients are limited due to rare incidence, and difficulty in obtaining patient heart biopsies in the pre- or post-symptomatic phase. Therefore, in order to study both functional and molecular changes in vitro, here we utilized a human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and multicellular cardiac organoids (COs).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264319" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE318809 é€šè¿‡å•ç»†èƒè½¬å½•ç»„å­¦è§£æè„†å¼±æ‹Ÿæ†èŒä¸­å™¬èŒä½“-å®¿ä¸»ç›¸äº’ä½œç”¨çš„åŠ¨æ€[æ‰¹é‡RNA-Seqæ•°æ®]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€single-cellã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Norma Morella ; Neelendu Dey ; Anika Gupta ; Dmitry Sutormin ; Anna KuchinaSeries Type : Expression profiling by high throughput sequencingOrganism : Bacteroides fragilisSuccess of phage therapies is limited by bacterial defenses against phages. While a variety of anti-phage defense mechanisms has been characterized, how expression of these systems is distributed across individual cells and how their combined activities translate into protection from phages has not been studied. Using bacterial single-cell RNA sequencing, we profiled the transcriptomes of ~50,000 cells from cultures of a human pathobiont, Bacteroides fragilis, infected with a lytic bacteriophage. We quantified the asynchronous progression of phage infection in single bacterial cells and reconstructed the infection timeline, characterizing both host and phage transcriptomic changes as infection unfolded. We discovered subpopulations of bacteria that remained uninfected and heterogeneously expressed protective factors. Each cellâ€™s vulnerability to phage infection was defined by combinatorial expression of multiple genetic loci, including phase-variable capsular polysaccharide (CPS) biosynthesis pathways, restriction-modification systems (RM), and a novel operon predicted to encode fimbrial genes. Acting in concert, these heterogeneously expressed anti-phage defense mechanisms create a phenotypic landscape where distinct protective combinations enable the survival and re-growth of bacteria expressing these phenotypes without acquiring additional mutations. The emerging model of complementary action of multiple protective mechanisms heterogeneously expressed across an isogenic bacterial population showcases the potent role of phase variation and stochasticity in bacterial anti-phage defenses.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318809" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>GSE309282 å•ç»†èƒ RNA æµ‹åº (scRNA-seq) ç ”ç©¶äº†å°é¼ ç¬¬ä¸€ç£¨ç‰™åŠå…¶é‚»è¿‘ç‰™æ§½éª¨ç»„ç»‡åœ¨æ­£ç•¸è´Ÿè·ä½œç”¨ä¸‹å’Œæœªè´Ÿè·ä½œç”¨ä¸‹çš„ RNA æ°´å¹³å˜åŒ–ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Miao Tan ; Minyu HeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSingle-cell RNA sequencing (scRNA-seq) was performed on mouse first molar and adjacent alveolar bone tissues (within 1 mm, buccal and palatal sides). Two groups were analyzed: non-loaded control and orthodontic tooth movement (OTM) after 1 day. The study aims to reveal early cellular and transcriptional changes induced by orthodontic force.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309282" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE300367 åˆ†æå¹²ç»†èƒæ¥æºçš„å¿ƒè„ç±»å™¨å®˜å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„å…ç–«éä¾èµ–æ€§ååº” [scRNAseq_Mouse]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€cardiac<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dilip Thomas ; Yu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe use of antibody based immune-checkpoint inhibitors (ICIs) have been highly successful in clinical treatment of several cancers. Despite the compelling efficacy of these drugs with their high binding affinity, there is incomplete understanding of non-target interactions in vivo. In this regard, ICIs are also known to cause immune-related adverse events (iRAEs) arising from infiltration of immune cells in tissues such as the heart. Due to the frequency of ICI treatments, extended half-life and the late onset of cardiac events, concerns have been raised regarding potential direct interactions of ICIs with major cellular cell types of the heart. The direct effects of these drugs in patients are limited due to rare incidence, and difficulty in obtaining patient heart biopsies in the pre- or post-symptomatic phase. Therefore, in order to study both functional and molecular changes in vitro and in vivo, we utilized a human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs), cardiac organoids (COs), and immunocompromised NOD/SCID mouse models.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300367" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE296370 å„¿ç«¥å’Œé’å°‘å¹´ä¼¯åŸºç‰¹ç™½è¡€ç—…å’Œæ·‹å·´ç˜¤ä¸­çš„ miRNA ç‰¹å¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€lymphoma<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : BjÃ¶rn Schneider ; Teresa M Cardesa-SalzmannSeries Type : Expression profiling by arrayOrganism : Homo sapiensmiRNA expression analysis in Burkitt leukemia and lymphoma in children and young adults. Comparison of clinicopathological subgroups. Evaluation of differential expression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296370" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE263840 åˆ†æå¹²ç»†èƒæ¥æºçš„å¿ƒè„ç±»å™¨å®˜å¯¹å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„éå…ç–«ä¾èµ–æ€§ååº”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€cardiac<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dilip Thomas ; Yu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe use of antibody based immune-checkpoint inhibitors (ICIs) have been highly successful in clinical treatment of several cancers. Despite the compelling efficacy of these drugs with their high binding affinity, there is incomplete understanding of non-target interactions in vivo. In this regard, ICIs are also known to cause immune-related adverse events (iRAEs) arising from infiltration of immune cells in tissues such as the heart. Due to the frequency of ICI treatments, extended half-life and the late onset of cardiac events, concerns have been raised regarding potential direct interactions of ICIs with major cellular cell types of the heart. The direct effects of these drugs in patients are limited due to rare incidence, and difficulty in obtaining patient heart biopsies in the pre- or post-symptomatic phase. Therefore, in order to study both functional and molecular changes in vitro, here we utilized a human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and multicellular cardiac organoids (COs).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263840" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE303002 SMARCA5â€“DMRT1 å…ˆé”‹å¤åˆç‰©å»ºç«‹è¡¨è§‚é—ä¼ å¯åŠ¨ä»¥æŒ‡å¯¼é›„æ€§ç”Ÿæ®–ç»†èƒå‘è‚² [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Satoshi H Namekawa ; Yuka Kitamura ; Yasuhisa MunakataSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusEstablishing cell typeâ€“specific chromatin landscapes is essential for cellular identity, yet how these landscapes are generated and maintained remains poorly understood. Here, we demonstrate that the chromatin remodeler SMARCA5 facilitates epigenetic priming required for retinoic acidâ€“induced differentiation in the male germline. Germ cellâ€“specific deletion of Smarca5 results in a complete loss of differentiating spermatogonia, phenocopying vitamin Aâ€“deficient mice lacking retinoic acid signaling. During the perinatal transition from prospermatogonia to undifferentiated spermatogonia, SMARCA5 is recruited to DMRT1-binding sites located at distal putative enhancers and promoters of germline genes. The SMARCA5â€“DMRT1 pioneer complex establishes chromatin accessibility at these loci, generating poised enhancers and promoters that serve as retinoic acid receptor (RAR)â€“binding sites. Thus, SMARCA5 licenses transcriptional responses to retinoic acid that enable spermatogenic differentiation. Our findings uncover a critical epigenetic priming mechanism that links pioneer factor activity to external signal responsiveness in the germline.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303002" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE303001 SMARCA5â€“DMRT1 å…ˆé”‹å¤åˆç‰©å»ºç«‹è¡¨è§‚é—ä¼ å¯åŠ¨ä»¥æŒ‡å¯¼é›„æ€§ç”Ÿæ®–ç»†èƒå‘è‚² [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Satoshi H Namekawa ; Yuka Kitamura ; Yasuhisa MunakataSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusEstablishing cell typeâ€“specific chromatin landscapes is essential for cellular identity, yet how these landscapes are generated and maintained remains poorly understood. Here, we demonstrate that the chromatin remodeler SMARCA5 facilitates epigenetic priming required for retinoic acidâ€“induced differentiation in the male germline. Germ cellâ€“specific deletion of Smarca5 results in a complete loss of differentiating spermatogonia, phenocopying vitamin Aâ€“deficient mice lacking retinoic acid signaling. During the perinatal transition from prospermatogonia to undifferentiated spermatogonia, SMARCA5 is recruited to DMRT1-binding sites located at distal putative enhancers and promoters of germline genes. The SMARCA5â€“DMRT1 pioneer complex establishes chromatin accessibility at these loci, generating poised enhancers and promoters that serve as retinoic acid receptor (RAR)â€“binding sites. Thus, SMARCA5 licenses transcriptional responses to retinoic acid that enable spermatogenic differentiation. Our findings uncover a critical epigenetic priming mechanism that links pioneer factor activity to external signal responsiveness in the germline.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303001" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 42 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€ç§ç§˜å¯†çš„ç»†èƒè”ç›Ÿæˆ–è®¸å¯ä»¥è§£é‡Šåµå·¢ç™Œä¸ºä½•å¦‚æ­¤è‡´å‘½ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new tissue. These helper cells lead the way, allowing cancer to spread faster and resist chemotherapy. The findings uncover a critical weakness that future treatments may target.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260209064254.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>8</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>7</td>
</tr>
<tr>
<td>immune</td>
<td>7</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>4</td>
</tr>
<tr>
<td>cardiac</td>
<td>4</td>
</tr>
<tr>
<td>epigenetic</td>
<td>4</td>
</tr>
<tr>
<td>metabolic</td>
<td>4</td>
</tr>
<tr>
<td>aging</td>
<td>4</td>
</tr>
<tr>
<td>carcinoma</td>
<td>3</td>
</tr>
<tr>
<td>scRNA</td>
<td>3</td>
</tr>
<tr>
<td>leukemia</td>
<td>3</td>
</tr>
<tr>
<td>transcriptome</td>
<td>3</td>
</tr>
<tr>
<td>single-cell</td>
<td>3</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>3</td>
</tr>
<tr>
<td>Alzheimer</td>
<td>3</td>
</tr>
<tr>
<td>spatial</td>
<td>2</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>sequencing</td>
<td>2</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>2</td>
</tr>
<tr>
<td>lymphoma</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (42æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297490" target="_blank" rel="noopener noreferrer">GSE297490 APPåŸºå› ä¸­ä¸é˜¿å°”èŒ¨æµ·é»˜ç—…ç›¸å…³çš„çªå˜ä»¥æ€§åˆ«ä¾èµ–çš„æ–¹å¼å½±å“ç»“ç›´è‚ è‚¿ç˜¤çš„å½¢æˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282025" target="_blank" rel="noopener noreferrer">GSE282025ï¼šåšæ¥éœ‰ç´ è¯±å¯¼è‚ºçº¤ç»´åŒ–æ¨¡å‹ä¸­Tubb3-/-å°é¼ è‚ºç»„ç»‡çš„å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264596" target="_blank" rel="noopener noreferrer">GSE264596 XPO7-NPATè½´ä»£è¡¨TP53çªå˜æ€¥æ€§é«“ç³»ç™½è¡€ç—…çš„å…³é”®è„†å¼±æ€§ï¼ˆscRNA-Seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304483" target="_blank" rel="noopener noreferrer">GSE304483 è‚è„è¿åŠ¨å› å­é€šè¿‡é¶å‘è„‘è¡€ç®¡é€†è½¬è¡°è€å’Œé˜¿å°”èŒ¨æµ·é»˜ç—…ç›¸å…³çš„è®°å¿†ä¸§å¤±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317004" target="_blank" rel="noopener noreferrer">GSE317004 å¿ƒè‚Œæ¢—æ­»å’ŒNKç»†èƒè€—ç«­å°é¼ å¿ƒè„CD45+ç™½ç»†èƒçš„CITE-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307094" target="_blank" rel="noopener noreferrer">GSE307094 é˜¿å°”èŒ¨æµ·é»˜ç—…æˆäººç¥ç»å‘ç”Ÿæ¨¡å‹ä¸­å•ç»†èƒè½¬å½•æ¨¡å¼å—æŸ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285110" target="_blank" rel="noopener noreferrer">GSE285110 éåæ­»æ€§å‡‹äº¡ MLKL åŠŸèƒ½æŸä¼¤çº¿ç²’ä½“å¹¶ä¿ƒè¿›é€ è¡€å¹²ç»†èƒè¡°è€ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285109" target="_blank" rel="noopener noreferrer">GSE285109 éåæ­»æ€§å‡‹äº¡ MLKL åŠŸèƒ½æŸä¼¤çº¿ç²’ä½“å¹¶ä¿ƒè¿›é€ è¡€å¹²ç»†èƒè¡°è€ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279282" target="_blank" rel="noopener noreferrer">GSE279282 è·¨ç¥–å…ˆäººç¾¤è‚¾ç™Œæ˜“æ„Ÿæ€§å› æœå…³ç³»çš„é—ä¼ æ™¯è§‚å’ŒåŠŸèƒ½æ¢ç´¢ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317434" target="_blank" rel="noopener noreferrer">GSE317434 ç”¨å¯¹ç…§ siRNA æˆ– FH siRNA è½¬æŸ“çš„ BJ æˆçº¤ç»´ç»†èƒçš„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317294" target="_blank" rel="noopener noreferrer">GSE317294 æ•´åˆè½¬å½•ç»„åˆ†ææ­ç¤ºäº†çŒªæ»‹å…»å±‚ç»†èƒä¸­æ—¥æœ¬è„‘ç‚ç—…æ¯’æ„ŸæŸ“çš„ miRNA ä¸­å¿ƒè°ƒæ§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316548" target="_blank" rel="noopener noreferrer">GSE316548 [18F]FDG PET/CT å¤šç»„å­¦é‰´å®šå‡º Hedgehog é©±åŠ¨çš„ HPV é˜´æ€§å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300899" target="_blank" rel="noopener noreferrer">GSE300899 å¹¿æ³›çš„å¢å¼ºå­ä¸²æ‰°æ§åˆ¶è„‚è‚ªç”Ÿæˆè°±ç³»å®šå‘è¿‡ç¨‹ä¸­ PPARG2 è¡¨è¾¾çš„è¯±å¯¼ [Chip-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288814" target="_blank" rel="noopener noreferrer">GSE288814 è¡¨è§‚è½¬å½•ç»„åˆ†ææ­ç¤ºäº†ä¸¤ç§è¥¿ç“œæ„ŸæŸ“çš„ RNA ç—…æ¯’ä¸­ä¸å­˜åœ¨ m6A ä¿®é¥° [GLORI-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288813" target="_blank" rel="noopener noreferrer">GSE288813 è¡¨è§‚è½¬å½•ç»„åˆ†ææ­ç¤ºäº†ä¸¤ç§è¥¿ç“œæ„ŸæŸ“çš„ RNA ç—…æ¯’ä¸­ä¸å­˜åœ¨ m6A ä¿®é¥° [DRS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288812" target="_blank" rel="noopener noreferrer">GSE288812 è¡¨è§‚è½¬å½•ç»„åˆ†ææ­ç¤ºäº†ä¸¤ç§è¥¿ç“œæ„ŸæŸ“çš„ RNA ç—…æ¯’ä¸­ä¸å­˜åœ¨ m6A ä¿®é¥° [m6ARIPseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281778" target="_blank" rel="noopener noreferrer">GSE281778 MYC ä¸æ–°ç”Ÿ RNA çš„ç»“åˆé€šè¿‡ R ç¯è¡ç”Ÿçš„ RNA-DNA æ‚äº¤ä½“æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼ [seCLIP]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281614" target="_blank" rel="noopener noreferrer">GSE281614 RNAä»‹å¯¼çš„MYCå¤šèšåŒ–æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼[mRNA]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281612" target="_blank" rel="noopener noreferrer">GSE281612 MYC ä¸æ–°ç”Ÿ RNA çš„ç»“åˆé€šè¿‡ R ç¯è¡ç”Ÿçš„ RNA-DNA æ‚äº¤ä½“æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼ [DRIPc]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281611" target="_blank" rel="noopener noreferrer">GSE281611 MYC ä¸æ–°ç”Ÿ RNA çš„ç»“åˆé€šè¿‡ R ç¯è¡ç”Ÿçš„ RNA-DNA æ‚äº¤ä½“æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼ [ChIP_Rx]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249809" target="_blank" rel="noopener noreferrer">GSE249809 RNA 5-ç”²åŸºèƒå˜§å•¶å†™å…¥é…¶NSUN5é€šè¿‡ZBED3ä¾èµ–æ€§æœºåˆ¶ä¿ƒè¿›è‚ç»†èƒç™Œç»†èƒå¢æ®–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318963" target="_blank" rel="noopener noreferrer">GSE318963 èˆ’å°¼æ›¿å°¼é€šè¿‡æŠ‘åˆ¶é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œç»†èƒä¸­çš„DNAä¿®å¤é€šè·¯ä¸é¡ºé“‚äº§ç”ŸååŒä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318878" target="_blank" rel="noopener noreferrer">GSE318878 Tç»†èƒå‰æ·‹å·´ç»†èƒç™½è¡€ç—…ä¸­çš„microRNAç½‘ç»œåæ˜ Tç»†èƒæ´»åŒ–å¹¶å¡‘é€ DNAæŸä¼¤ååº”å’Œç”Ÿå­˜é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308162" target="_blank" rel="noopener noreferrer">GSE308162 è¯„ä¼° miRomics å’Œæ•´åˆè›‹ç™½è´¨ç»„å­¦åœ¨é‰´å®šè¡€æµ† miRNA ä½œä¸º IFNÎ²-1a ç”Ÿç‰©åˆ¶å‰‚æ½œåœ¨è¯æ•ˆå­¦ç”Ÿç‰©æ ‡å¿—ç‰©ä¸­çš„åº”ç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303063" target="_blank" rel="noopener noreferrer">GSE303063 SMARCA5â€“DMRT1 å…ˆé”‹å¤åˆç‰©å»ºç«‹è¡¨è§‚é—ä¼ å¯åŠ¨ä»¥æŒ‡å¯¼é›„æ€§ç”Ÿæ®–ç»†èƒå‘è‚²</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303000" target="_blank" rel="noopener noreferrer">GSE303000 SMARCA5â€“DMRT1 å…ˆé”‹å¤åˆç‰©å»ºç«‹è¡¨è§‚é—ä¼ å¯åŠ¨ä»¥æŒ‡å¯¼é›„æ€§ç”Ÿæ®–ç»†èƒå‘è‚² [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300910" target="_blank" rel="noopener noreferrer">GSE300910 å‘¼å¸é“åˆèƒç—…æ¯’æ„ŸæŸ“é€šè¿‡è¯±å¯¼è®­ç»ƒå…ç–«å’ŒSARS-CoV-2ååº”æ€§é»è†œTç»†èƒï¼Œè¯±å¯¼é’ˆå¯¹SARS-CoV-2çš„å¼‚æºæ€§ä¿æŠ¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299672" target="_blank" rel="noopener noreferrer">GSE299672 PHIPæŠ‘åˆ¶NuRDä¿ƒè¿›SWI/SNFçªå˜ç™Œç—‡çš„ç”Ÿé•¿[ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299562" target="_blank" rel="noopener noreferrer">GSE299562 PHIPæŠ‘åˆ¶NuRDä¿ƒè¿›SWI/SNFçªå˜ç™Œç—‡çš„ç”Ÿé•¿[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296927" target="_blank" rel="noopener noreferrer">GSE296927 Notché…ä½“Jagged1è°ƒæ§ä¸‰é˜´æ€§ä¹³è…ºç™Œç»†èƒå¤–åŸºè´¨çš„äº§ç”Ÿå’Œç»„ç»‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268200" target="_blank" rel="noopener noreferrer">GSE268200 éä¿ƒæœ‰ä¸åˆ†è£‚ FGF19 mRNA ç–—æ³•ç”¨äºæ²»ç–—å®éªŒæ€§ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³è„‚è‚ªè‚ç—… (MASLD)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE179870" target="_blank" rel="noopener noreferrer">GSE179870 å¤šç§ç»†èƒç±»å‹ä¸­ m6A è¯»æ•°çš„åˆ†å¸ƒå›¾ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318652" target="_blank" rel="noopener noreferrer">GSE318652 P21+TREM2+-è¡°è€å·¨å™¬ç»†èƒä¿ƒè¿›ç‚ç—‡è¡°è€å’Œä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³çš„è„‚è‚ªè‚ç–¾ç—…[RNAseq_MASHABT263]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318651" target="_blank" rel="noopener noreferrer">GSE318651 P21+TREM2+-è¡°è€å·¨å™¬ç»†èƒä¿ƒè¿›ç‚ç—‡è¡°è€å’Œä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³çš„è„‚è‚ªè‚ç–¾ç—…[RNAseq_sgCMPK2]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318428" target="_blank" rel="noopener noreferrer">GSE318428 æ•´åˆè½¬å½•ç»„å­¦å’Œä»£è°¢ç»„å­¦åˆ†ææ­ç¤ºäº†ä¸¤ç§åŸ¹å…»æ¡ä»¶ä¸‹ RPE ç»†èƒä¸åŒçš„èƒ½é‡ä»£è°¢ç‰¹å¾å’ŒåŠŸèƒ½ç‰¹æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289238" target="_blank" rel="noopener noreferrer">GSE289238 ç»“è‚ ç‚ç›¸å…³ç™Œä¸Šçš®ç±»å™¨å®˜å•ç‹¬æˆ–ä¸åŒ¹é…çš„è¿‘ç«¯ç»“è‚ æˆçº¤ç»´ç»†èƒæˆ–ä¸åŒ¹é…çš„ç»“è‚ ç‚ç›¸å…³ç™Œæˆçº¤ç»´ç»†èƒè¿›è¡Œä½“å†…å…±åŸ¹å…»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289177" target="_blank" rel="noopener noreferrer">GSE289177 éšå°¾èŸ‘è‚å•ç»†èƒæ ¸è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285111" target="_blank" rel="noopener noreferrer">GSE285111 éåæ­»æ€§å‡‹äº¡çš„MLKLåŠŸèƒ½æŸä¼¤çº¿ç²’ä½“å¹¶ä¿ƒè¿›é€ è¡€å¹²ç»†èƒè¡°è€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279473" target="_blank" rel="noopener noreferrer">GSE279473 è·¨ç¥–å…ˆäººç¾¤è‚¾ç™Œæ˜“æ„Ÿæ€§å› æœå…³ç³»çš„é—ä¼ å›¾è°±å’ŒåŠŸèƒ½æ¢ç´¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279304" target="_blank" rel="noopener noreferrer">GSE279304 è·¨ç¥–å…ˆäººç¾¤è‚¾ç™Œæ˜“æ„Ÿæ€§å› æœå…³ç³»çš„é—ä¼ æ™¯è§‚å’ŒåŠŸèƒ½æ¢ç´¢ [ç­›é€‰]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279303" target="_blank" rel="noopener noreferrer">GSE279303 è·¨ç¥–å…ˆäººç¾¤è‚¾ç™Œæ˜“æ„Ÿæ€§å› æœå…³ç³»çš„é—ä¼ æ™¯è§‚å’ŒåŠŸèƒ½æ¢ç´¢ [CUTnTag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279287" target="_blank" rel="noopener noreferrer">GSE279287 è·¨ç¥–å…ˆäººç¾¤è‚¾ç™Œæ˜“æ„Ÿæ€§å› æœå…³ç³»çš„é—ä¼ å›¾è°±å’ŒåŠŸèƒ½æ¢ç´¢ [CROP-seq]</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-10 22:03</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>